Singapore markets closed

IDEXX Laboratories, Inc. (0J8P.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
490.46-2.69 (-0.55%)
As of 07:03PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.33
52-week change 314.91%
S&P500 52-week change 322.55%
52-week high 3583.30
52-week low 30.00
50-day moving average 3548.90
200-day moving average 3498.86

Share statistics

Avg vol (3-month) 31.08k
Avg vol (10-day) 3803
Shares outstanding 586.23M
Implied shares outstanding 6N/A
Float 881.7M
% held by insiders 10.93%
% held by institutions 192.68%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 23.26%
Operating margin (ttm)31.01%

Management effectiveness

Return on assets (ttm)22.63%
Return on equity (ttm)71.91%

Income statement

Revenue (ttm)3.72B
Revenue per share (ttm)44.83
Quarterly revenue growth (yoy)7.10%
Gross profit (ttm)N/A
EBITDA 1.23B
Net income avi to common (ttm)866.57M
Diluted EPS (ttm)8.52
Quarterly earnings growth (yoy)10.10%

Balance sheet

Total cash (mrq)397.43M
Total cash per share (mrq)4.81
Total debt (mrq)1.07B
Total debt/equity (mrq)68.13%
Current ratio (mrq)1.57
Book value per share (mrq)18.93

Cash flow statement

Operating cash flow (ttm)921.18M
Levered free cash flow (ttm)733.09M